tm logo
ASCENTAGE PHARMA
Live/Registered
REGISTERED

on 23 Nov 2021

Last Applicant/ Owned by

No. 1 Medical City Ave

Taizhou, Jiangsu

CN

225300

Serial Number

90039971 filed on 07th Jul 2020

Registration Number

6565245 registered on 23rd Nov 2021

in the Principal Register

Correspondent Address

Kelu L. Sullivan

Kelu L. Sullivan

1300 19TH STREET, NW, SUITE 300

WASHINGTON, DC 20036

Filing Basis

1. intent to use

Disclaimer

NO DATA

ASCENTAGE PHARMA

Medicines for dental purposes; chemical preparations for medical purposes for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antibiotics; medicine for injection for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-rela Read More

Classification Information


Class [005]
Pharmaceutical Products


Medicines for dental purposes; chemical preparations for medical purposes for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antibiotics; medicine for injection for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; medicinal tablets, for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; bulk drugs, namely, pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease sold in bulk; biochemical medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antiseptics; collyrium; suppositories being pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; plasters for medical purposes; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; medicated candy; candy for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic preparations adapted for medical use; oil solutions, namely, medicinal oils; mineral food supplements; nutritional supplements; medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; bacterial poisons; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biological preparations for medical purposes for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical purposes, for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease

Class [042]
Computer & Software Services & Scientific Services


Analysis of the mode of action of chemical combinations on animals; scientific research for medical purposes in the area of cancerous diseases; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research services; scientific investigations for medical purposes; chemical analysis services; biochemical research and analysis; chemical research services; working on and evaluation of chemical analyses; chemical research and analysis; working on and evaluation of chemical syntheses; chemical analysis; chemistry services in the nature of chemist services; chemical research; cosmetics research; structural and functional analysis of genomes; stem cell research services; biotechnology research; blood analysis services; genetic screening for scientific research purposes; biological cloning services; research and development services in the field of antibodies; genetic testing for scientific research purposes; bacteriological research and analysis; biomedical research services; medical research; drug discovery services; medical laboratory services; development of pharmaceutical preparations and medicines; medical research services; biological research and analysis; bacteriological research; biological research; conducting clinical trials for others; computer programming in the medical field; pharmaceutical product evaluation; research on the subject of pharmaceuticals

Mark Details


Serial Number

No 90039971

Mark Type

No Service Mark

Attorney Docket Number

No 463.0001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.06 -

Semi-circles

Legal History


Show more

Status DateAction Taken
23rd Nov 2021REGISTERED-PRINCIPAL REGISTER
07th Sep 2021PUBLISHED FOR OPPOSITION
07th Sep 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18th Aug 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03rd Aug 2021ELECTRONIC RECORD REVIEW COMPLETE
30th Jul 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
28th Jul 2021APPROVED FOR PUB - PRINCIPAL REGISTER
28th Jul 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
28th Jul 2021TEAS/EMAIL CORRESPONDENCE ENTERED
28th Jul 2021CORRESPONDENCE RECEIVED IN LAW OFFICE